{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T01:19:47Z","timestamp":1793582387303,"version":"4.5.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["1017886"],"award-info":[{"award-number":["1017886"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Epilepsy and neurocysticercosis (NCC) prevalence estimates in sub-Saharan Africa are still scarce but show important variation due to the population studied and different screening and diagnosis strategies used. The aims of this study were to estimate the prevalence of epileptic seizures and epilepsy in the sampled population, and the proportion of NCC among people with epilepsy (PWE) in a large cross-sectional study in a rural district of southern Malawi.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We conducted a community-based door-to-door screening study for epileptic seizures in Balaka, Malawi between October and December 2012. Past epileptic seizures were reported through a 15-item questionnaire answered by at least one person per household generating five major criteria. People who screened positive were further examined by a neurologist to establish diagnosis. Patients diagnosed with epilepsy were examined and offered <jats:italic>Taenia solium<\/jats:italic> cyst antigen and antibody serological tests, and a CT scan for the diagnosis of NCC.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>In total, screening information on 69,595 individuals was obtained for lifetime occurrence of epileptic seizures. 3,100 (4.5%) participants screened positive, of whom 1,913 (62%) could be followed-up and underwent further assessment. Lifetime prevalence was 3.0% (95% Bayesian credible interval [CI] 2.8 to 3.1%) and 1.2% (95%BCI 0.9 to 1.6%) for epileptic seizures and epilepsy, respectively. NCC prevalence among PWE was estimated to be 4.4% (95%BCI 0.8 to 8.5%). A diagnosis of epilepsy was ultimately reached for 455 participants.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The results of this large community-based study contribute to the evaluation and understanding of the burden of epilepsy in the population and of NCC among PWE in sub-Saharan Africa.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0010675","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T17:57:13Z","timestamp":1663264633000},"page":"e0010675","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Community-level prevalence of epilepsy and of neurocysticercosis among people with epilepsy in the Balaka district of Malawi: A cross-sectional study"],"prefix":"10.1371","volume":"16","author":[{"given":"Luise","family":"Keller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6743-2818","authenticated-orcid":true,"given":"Dominik","family":"Stelzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Carabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kristin","family":"Reinhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara M.","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Action","family":"Amos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Boeckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3131-6983","authenticated-orcid":true,"given":"Andrea S.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"pntd.0010675.ref001","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"key":"pntd.0010675.ref002","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"AK Ngugi","year":"2010","journal-title":"Epilepsia"},{"key":"pntd.0010675.ref003","doi-asserted-by":"crossref","first-page":"e1000162","DOI":"10.1371\/journal.pmed.1000162","article-title":"Packages of care for epilepsy in low- and middle-income countries","volume":"6","author":"CK Mbuba","year":"2009","journal-title":"PLoS Med."},{"key":"pntd.0010675.ref004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1179\/2047773212Y.0000000047","article-title":"Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management","volume":"106","author":"AS Winkler","year":"2012","journal-title":"Pathog Glob Health"},{"key":"pntd.0010675.ref005","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.seizure.2017.10.004","article-title":"Neurocysticercosis as an infectious acquired epilepsy worldwide","volume":"52","author":"DS Reddy","year":"2017","journal-title":"Seizure"},{"key":"pntd.0010675.ref006","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/313470","article-title":"Magnitude of the disease burden from neurocysticercosis in a developing country","volume":"29","author":"C Bern","year":"1999","journal-title":"Clin Infect Dis"},{"key":"pntd.0010675.ref007","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4103\/1319-2442.279948","article-title":"Neurocysticercosis","volume":"31","author":"T Siddiqua","year":"2020","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"pntd.0010675.ref008","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(05)70194-0","article-title":"Neurocysticercosis: updated concepts about an old disease","volume":"4","author":"HH Garcia","year":"2005","journal-title":"Lancet Neurol"},{"key":"pntd.0010675.ref009","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1586\/ern.11.86","article-title":"Corticosteroid use in neurocysticercosis","volume":"11","author":"TE Nash","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"pntd.0010675.ref010","doi-asserted-by":"crossref","first-page":"e2562","DOI":"10.1371\/journal.pntd.0002562","article-title":"Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts","volume":"7","author":"JD Keenan","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010675.ref011","doi-asserted-by":"crossref","first-page":"20130434","DOI":"10.1098\/rstb.2013.0434","article-title":"The contribution of mass drug administration to global health: past, present and future","volume":"369","author":"JP Webster","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"pntd.0010675.ref012","doi-asserted-by":"crossref","first-page":"e1152","DOI":"10.1371\/journal.pntd.0001152","article-title":"Clinical manifestations associated with neurocysticercosis: a systematic review","volume":"5","author":"H Carabin","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010675.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2020.01.005","article-title":"Neurocysticercosis in people with epilepsy in Sub-Saharan Africa: A systematic review and meta-analysis of the prevalence and strength of association","volume":"76","author":"LF Owolabi","year":"2020","journal-title":"Seizure"},{"key":"pntd.0010675.ref014","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1528-1167.2008.01867.x","article-title":"Epilepsy and neurocysticercosis in rural Tanzania-An imaging study","volume":"50","author":"AS Winkler","year":"2009","journal-title":"Epilepsia"},{"key":"pntd.0010675.ref015","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/epi.12811","article-title":"The diagnostic accuracy of screening questionnaires for the identification of adults with epilepsy: a systematic review","volume":"55","author":"MR Keezer","year":"2014","journal-title":"Epilepsia"},{"key":"pntd.0010675.ref016","first-page":"369","article-title":"Epidemiology of Epilepsy in Low- and Middle-Income Countries: Experience of a Standardized Questionnaire over the Past Two Decades","volume":"55","author":"M Vergonjeanne","year":"2021"},{"key":"pntd.0010675.ref017","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.molbiopara.2006.02.004","article-title":"Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis","volume":"147","author":"K Hancock","year":"2006","journal-title":"Mol Biochem Parasitol"},{"key":"pntd.0010675.ref018","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1128\/JCM.03260-13","article-title":"Recombinant protein- and synthetic peptide-based immunoblot test for diagnosis of neurocysticercosis","volume":"52","author":"J Noh","year":"2014","journal-title":"J Clin Microbiol"},{"key":"pntd.0010675.ref019","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ijpara.2003.11.014","article-title":"A Bayesian approach for estimating values for prevalence and diagnostic test characteristics of porcine cysticercosis","volume":"34","author":"P Dorny","year":"2004","journal-title":"Int J Parasitol"},{"key":"pntd.0010675.ref020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jns.2016.11.045","article-title":"Revised diagnostic criteria for neurocysticercosis","volume":"372","author":"OH Del Brutto","year":"2017","journal-title":"J Neurol Sci"},{"key":"pntd.0010675.ref021","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.0006-341X.2004.00183.x","article-title":"Bayesian sample size determination for prevalence and diagnostic test studies in the absence of a gold standard test","volume":"60","author":"N Dendukuri","year":"2004","journal-title":"Biometrics"},{"key":"pntd.0010675.ref022","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/cncy.21503","article-title":"Verification and classification bias interactions in diagnostic test accuracy studies for fine-needle aspiration biopsy","volume":"123","author":"RL Schmidt","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"pntd.0010675.ref023","doi-asserted-by":"crossref","first-page":"e0007109","DOI":"10.1371\/journal.pntd.0007109","article-title":"The impact of imperfect screening tools on measuring the prevalence of epilepsy and headaches in Burkina Faso","volume":"13","author":"I Sahlu","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010675.ref024","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1474-4422(14)70114-0","article-title":"Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa","volume":"13","author":"A Ba-Diop","year":"2014","journal-title":"Lancet Neurol"},{"key":"pntd.0010675.ref025","article-title":"rjags: Bayesian Graphical Models using MCMC","author":"M. Plummer","year":"2019","journal-title":"R package version 4\u201310"},{"key":"pntd.0010675.ref026","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.eplepsyres.2013.11.010","article-title":"Epilepsy prevalence, potential causes and social beliefs in Ebonyi State and Benue State, Nigeria","volume":"108","author":"C Osakwe","year":"2014","journal-title":"Epilepsy Research"},{"key":"pntd.0010675.ref027","doi-asserted-by":"crossref","first-page":"100352","DOI":"10.1016\/j.ensci.2021.100352","article-title":"Lifetime prevalence of epilepsy in urban Tanzania\u2014A door-to-door random cluster survey","volume":"24","author":"D Stelzle","year":"2021","journal-title":"eNeurologicalSci"},{"key":"pntd.0010675.ref028","doi-asserted-by":"crossref","first-page":"106846","DOI":"10.1016\/j.yebeh.2019.106846","article-title":"Prevalence of active epilepsy, lifetime epilepsy prevalence, and burden of epilepsy in Sub-Saharan Africa from meta-analysis of door-to-door population-based surveys","volume":"103","author":"LF Owolabi","year":"2020","journal-title":"Epilepsy Behav."},{"key":"pntd.0010675.ref029","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(13)70003-6","article-title":"Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies","volume":"12","author":"AK Ngugi","year":"2013","journal-title":"Lancet Neurol"},{"key":"pntd.0010675.ref030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1474-4422(07)70292-2","article-title":"Active convulsive epilepsy in a rural district of Kenya: a study of prevalence and possible risk factors","volume":"7","author":"T Edwards","year":"2008","journal-title":"Lancet Neurol"},{"key":"pntd.0010675.ref031","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000327496","article-title":"Determining the burden of neurological disorders in populations living in tropical areas: who would be questioned? Lessons from a Mexican rural community","volume":"36","author":"F Quet","year":"2011","journal-title":"Neuroepidemiology"},{"key":"pntd.0010675.ref032","first-page":"67","article-title":"Epidemiological profile of epilepsy in low income populations","volume":"56","author":"C Espinosa-Jovel","year":"2018","journal-title":"SeizureEpub 2018"},{"key":"pntd.0010675.ref033","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4103\/0971-5916.198686","article-title":"Neurocysticercosis: Diagnostic problems & current therapeutic strategies","volume":"144","author":"V. Rajshekhar","year":"2016","journal-title":"Indian J Med Res"},{"key":"pntd.0010675.ref034","doi-asserted-by":"crossref","first-page":"e870","DOI":"10.1371\/journal.pntd.0000870","article-title":"A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy","volume":"4","author":"PC Ndimubanzi","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010675.ref035","doi-asserted-by":"crossref","first-page":"e562","DOI":"10.1371\/journal.pntd.0000562","article-title":"Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa","volume":"3","author":"H Foyaca-Sibat","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010675.ref036","author":"Pan American Health Organization","year":"2021","journal-title":"Guideline for Preventive Chemotherapy for the Control of Taenia solium Taeniasis"},{"key":"pntd.0010675.ref037","doi-asserted-by":"crossref","first-page":"e0173945","DOI":"10.1371\/journal.pone.0173945","article-title":"A screening questionnaire for convulsive seizures: A three-stage field-validation in rural Bolivia","volume":"12","author":"L Giuliano","year":"2017","journal-title":"PLoS One"},{"key":"pntd.0010675.ref038","doi-asserted-by":"crossref","first-page":"598","DOI":"10.7326\/0003-4819-137-7-200210010-00011","article-title":"Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation","volume":"137","author":"SA Mulherin","year":"2002","journal-title":"Ann Intern Med"},{"key":"pntd.0010675.ref039","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/epi.12579","article-title":"Prevalence of epilepsy\u2014an unknown quantity","volume":"55","author":"E Beghi","year":"2014","journal-title":"Epilepsia"},{"key":"pntd.0010675.ref040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.yebeh.2018.04.014","article-title":"Epilepsy misconceptions and stigma reduction interventions in sub-Saharan Africa, a systematic review","volume":"85","author":"M Kaddumukasa","year":"2018","journal-title":"Epilepsy Behav"},{"key":"pntd.0010675.ref041","doi-asserted-by":"crossref","first-page":"107604","DOI":"10.1016\/j.yebeh.2020.107604","article-title":"Translation and validation of an epilepsy-screening questionnaire in three Nigerian languages","volume":"114","author":"MM Watila","year":"2021","journal-title":"Epilepsy Behav."},{"key":"pntd.0010675.ref042","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1474-4422(08)70243-6","article-title":"Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study","volume":"7","author":"TE Nash","year":"2008","journal-title":"Lancet Neurol"},{"key":"pntd.0010675.ref043","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1212\/WNL.53.9.2064","article-title":"Prevalence of epilepsy in rural Bolivia: a door-to-door survey","volume":"53","author":"A Nicoletti","year":"1999","journal-title":"Neurology"},{"key":"pntd.0010675.ref044","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.seizure.2010.10.036","article-title":"Seizure in people with newly diagnosed active or transitional neurocysticercosis","volume":"20","author":"EA Kelvin","year":"2011","journal-title":"Seizure"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T17:58:00Z","timestamp":1663264680000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010675"}},"subtitle":[],"editor":[{"given":"Alessandra","family":"Nicoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0010675","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]}}}